Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| ciliated cell | 11 studies | 31% ± 14% | |
| epithelial cell | 7 studies | 28% ± 14% | |
| astrocyte | 6 studies | 28% ± 10% | |
| Mueller cell | 3 studies | 22% ± 6% | |
| goblet cell | 3 studies | 36% ± 28% | |
| transit amplifying cell | 3 studies | 20% ± 6% |
Insufficient scRNA-seq data for expression of RHPN2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 96% | 2904.68 | 236 / 245 | 100% | 111.24 | 500 / 502 |
| kidney | 100% | 1959.19 | 89 / 89 | 96% | 36.94 | 863 / 901 |
| pancreas | 100% | 780.73 | 327 / 328 | 93% | 47.26 | 166 / 178 |
| liver | 100% | 1365.43 | 226 / 226 | 88% | 22.22 | 358 / 406 |
| brain | 98% | 913.89 | 2591 / 2642 | 85% | 23.13 | 598 / 705 |
| stomach | 82% | 1670.15 | 294 / 359 | 98% | 63.61 | 281 / 286 |
| ovary | 76% | 256.94 | 136 / 180 | 99% | 55.28 | 424 / 430 |
| lung | 95% | 573.40 | 547 / 578 | 77% | 25.34 | 884 / 1155 |
| intestine | 67% | 1286.55 | 643 / 966 | 98% | 59.45 | 519 / 527 |
| breast | 67% | 1417.37 | 307 / 459 | 91% | 33.04 | 1021 / 1118 |
| uterus | 78% | 330.28 | 132 / 170 | 68% | 23.36 | 313 / 459 |
| thymus | 99% | 617.01 | 649 / 653 | 33% | 3.90 | 199 / 605 |
| skin | 79% | 1161.46 | 1432 / 1809 | 49% | 7.78 | 231 / 472 |
| bladder | 52% | 233.43 | 11 / 21 | 75% | 27.71 | 380 / 504 |
| ureter | 0% | 0 | 0 / 0 | 100% | 14.82 | 1 / 1 |
| esophagus | 24% | 62.94 | 348 / 1445 | 66% | 56.81 | 120 / 183 |
| adipose | 50% | 281.28 | 608 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 45% | 107.12 | 109 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 44% | 6.81 | 20 / 45 |
| heart | 32% | 82.71 | 276 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 19% | 112.40 | 173 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 18% | 2.46 | 14 / 80 |
| adrenal gland | 2% | 6.47 | 6 / 258 | 15% | 2.01 | 34 / 230 |
| blood vessel | 11% | 28.39 | 144 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 7% | 0.63 | 2 / 29 |
| muscle | 0% | 1.05 | 3 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007165 | Biological process | signal transduction |
| GO_0051497 | Biological process | negative regulation of stress fiber assembly |
| GO_0003094 | Biological process | glomerular filtration |
| GO_0005829 | Cellular component | cytosol |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0048471 | Cellular component | perinuclear region of cytoplasm |
| Gene name | RHPN2 |
| Protein name | Rhophilin Rho GTPase binding protein 2 Rhophilin-2 (76 kDa RhoB effector protein) (GTP-Rho-binding protein 2) (p76RBE) |
| Synonyms | |
| Description | FUNCTION: Binds specifically to GTP-Rho. May function in a Rho pathway to limit stress fiber formation and/or increase the turnover of F-actin structures in the absence of high levels of RhoA activity. . |
| Accessions | ENST00000254260.8 [Q8IUC4-1] K7EL35 Q8IUC4 ENST00000588388.5 |
